nach oben

Erschienen in:

09.10.2017 | PULMONARY VASCULAR DISEASE

Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH

verfasst von: Elena Pfeuffer, Holger Krannich, Michael Halank, Heinrike Wilkens, Philipp Kolb, Berthold Jany, Matthias Held

Erschienen in: Lung | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are life-threatening diseases with a high burden of symptoms. Although depression, anxiety, and reduced health related quality of life (HRQOL) have also been reported, a comparative analysis which explores these traits and their underlying factors was lacking.

Methods

A retrospective analysis of depression, anxiety, and health related QOL was conducted using a Hospital anxiety and depression scale (HADS) as well as the SF-36 HRQOL questionnaire. Results from these tools were compared with haemodynamic and functional parameters in 70 PAH and 23 CTEPH outpatients from a German tertiary care center specializing in pulmonary hypertension.

Results

Although HRQOL was reduced in both cohorts of patients, individuals diagnosed with CTEPH scored lower in nearly all SF-36 parameters. Significance was noted in both “mental health” (p = 0.01) and “mental component summary score” (MCS) (p = 0.02). Depression was also more frequent in patients with CTEPH (56%) than in patients with PAH (30%), (p = 0.03). Overall, depression and anxiety correlated with most SF-36 scales in both PAH and CTEPH. In CTEPH, depression also correlated with the Borg Dyspnea Scale (r = 0.44, p = 0.01). These patients also had significantly lower pCO₂ levels than the PAH cohort reflecting more severe ventilation/perfusion mismatch. All other haemodynamic and functional parameters did not differ across the groups.

Conclusion

While both cohorts of patients suffer from a reduced HRQOL as well as depression and anxiety, decreases in mental health parameters are more pronounced in the CTEPH cohort. This suggests a strong effort to improve early detection, especially in dyspneic patients with classical risk factors for CTEPH and PAH and argues for mental illness interventions alongside routine clinical care provided to patients diagnosed with PAH or CTEPH.

Nur mit Berechtigung zugänglich

Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119PubMedCrossRef

Hoeper MM, Bogaard HJ, Condliffe R et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D42–D50PubMedCrossRef

Hoeper MM, Huscher D, Ghofrani HA et al (2013) Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol 168(2):871–880PubMedCrossRef

Humbert M, Sitbon O, Chaouat A et al (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173(9):1023–1030PubMedCrossRef

Held M, Grun M, Holl R et al (2014) Chronic thromboembolic pulmonary hypertension: time delay from onset of symptoms to diagnosis and clinical condition at diagnosis. Dtsch Med Wochenschr 139(33):1647–1652PubMedCrossRef

Lewczuk J, Piszko P, Jagas J et al (2001) Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 119(3):818–823PubMedCrossRef

Wilkens H, Grimminger F, Hoeper M et al (2010) Burden of pulmonary arterial hypertension in Germany. Respir Med 104(6):902–910PubMedCrossRef

Rich JD, Rich S (2014) Clinical diagnosis of pulmonary hypertension. Circulation 130(20):1820–1830PubMedCrossRef

Rich S, Dantzker DR, Ayres SM et al (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107(2):216–223PubMedCrossRef

10.

Mayer E, Jenkins D, Lindner J et al (2011) Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 141(3):702–710PubMedCrossRef

11.

Badesch DB, Raskob GE, Elliott CG et al (2010) Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 137(2):376–387PubMedCrossRef

12.

Löwe B, Gräfe K, Ufer C et al (2004) Anxiety and depression in patients with pulmonary hypertension. Psychosom Med 66(6):831–836PubMedCrossRef

13.

Halank M, Einsle F, Lehman S et al (2013) Exercise capacity affects quality of life in patients with pulmonary hypertension. Lung 191(4):337–343PubMedCrossRef

14.

Harzheim D, Klose H, Pinado FP et al (2013) Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res 14:104PubMedPubMedCentralCrossRef

15.

Shafazand S, Goldstein MK, Doyle RL et al (2004) Health-related quality of life in patients with pulmonary arterial hypertension. Chest 126(5):1452–1459PubMedCrossRef

16.

Taichman DB, Shin J, Hud L et al (2005) Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 6:92PubMedPubMedCentralCrossRef

17.

McCollister DH, Beutz M, McLaughlin V et al (2010) Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status. Psychosomatics 51(4):339–339 e8PubMedCrossRef

18.

Looper KJ, Pierre A, Dunkley DM et al (2009) Depressive symptoms in relation to physical functioning in pulmonary hypertension. J Psychosom Res 66(3):221–225PubMedCrossRef

19.

Roman A, Barbera JA, Castillo MJ et al (2013) Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Arch Bronconeumol 49(5):181–188PubMedCrossRef

20.

Cenedese E, Speich R, Dorschner L et al (2006) Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 28(4):808–815PubMedCrossRef

21.

White J, Hopkins RO, Glissmeyer EW et al (2006) Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res 7:55PubMedPubMedCentralCrossRef

22.

Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):S2493–S2537CrossRef

23.

Remillard C, Yuan J (2008) Characterization of hemodynamics in patients with idiopathic and thromboembolic pulmonary hypertension. Clin Med Insights 2:59–68

24.

Baptista R, Meireles J, Agapito A et al (2013) Pulmonary hypertension in Portugal: first data from a nationwide registry. Biomed Res Int 2013:489574PubMedPubMedCentralCrossRef

25.

Mueller-Mottet S, Stricker H, Domenighetti G et al (2015) Long-term data from the Swiss pulmonary hypertension registry. Respiration 89(2):127–140PubMedCrossRef

26.

Parikh KS, Rajagopal S, Arges K et al (2015) Use of outcome measures in pulmonary hypertension clinical trials. Am Heart J 170(3):419–429PubMedCrossRef

27.

Strange G, Keogh AM, Williams TJ et al (2008) Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6 minute walk distance and quality of life. Respirology 13(5):674–682PubMedCrossRef

28.

Sastry BK, Narasimhan C, Reddy NK et al (2004) Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 43(7):1149–1153PubMedCrossRef

29.

Gihl A (2010) Health-related quality of life in pulmonary arterial hypertension. Adv Pulm Hypertens 8(4):215–222

30.

Ghofrani HA, D’Armini AM, Grimminger F et al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369(4):319–329PubMedCrossRef

31.

Mathai SC, Ghofrani HA, Mayer E et al (2016) Quality of life in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J 48(2):526–537PubMedPubMedCentralCrossRef

32.

Urushibara T, Tanabe N, Suda R et al (2015) Effects of surgical and medical treatment on quality of life for patients with chronic thromboembolic pulmonary hypertension. Circ J 79(12):2696–2702PubMedCrossRef

33.

Kirson NY, Birnbaum HG, Ivanova JI et al (2011) Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States. Curr Med Res Opin 27(9):1763–1768PubMedCrossRef

34.

Rosenkranz S, Behr J, Ewert R et al (2011) Right heart catheterization in pulmonary hypertension. Dtsch Med Wochenschr 136(50):2601–2616 quiz 2617-20 PubMedCrossRef

35.

Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685–713 quiz 786-8 PubMedCrossRef

36.

Society AT (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef

37.

American Thoracic S und American College of Chest P (2003) ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167(2):211–277CrossRef

38.

Meyer FJ, Borst MM, Buschmann HC et al (2013) Exercise testing in respiratory medicine. Pneumologie 67(1):16–34PubMedCrossRef

39.

Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14(5):377–381PubMedCrossRef

40.

Borg G (1998) Borg’s perceived exertion and pain scales. Human Kinetics, Champaign

41.

Snaith RP, Zigmond AS, Herrmann-Lingen C et al (1995) Hospital anxiety and depression scale: deutsche Version; HADS-D; ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin; Testdokumentation und Handanweisung. 1. Aufl (ed), Bern [u.a.]: Huber. 43, III S

42.

Bullinger M, Kirchberger I (1998) Fragebogen zum Gesundheitszustand: SF-36; Handanweisung. Göttingen [u.a.]: Hogrefe. 155 Seiten

43.

Bjelland I, Dahl AA, Haug TT et al (2002) The validity of the Hospital Anxiety and Depression Scale. an updated literature review. J Psychosom Res 52(2):69–77PubMedCrossRef

44.

Katon WJ (2003) Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54(3):216–226PubMedCrossRef

45.

Maurer J, Rebbapragada V, Borson S et al (2008) Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 134(4 Suppl):43S–56SPubMedCentralCrossRef

46.

Yohannes AM, Willgoss TG, Baldwin RC et al (2010) Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry 25(12):1209–1221PubMedCrossRef

47.

Jiang W, Kuchibhatla M, Cuffe MS et al (2004) Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 110(22):3452–3456PubMedCrossRef

48.

Ng TP, Niti M, Tan WC et al (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167(1):60–67PubMedCrossRef

49.

Coultas DB, Edwards DW, Barnett B et al (2007) Predictors of depressive symptoms in patients with COPD and health impact. COPD 4(1):23–28PubMedCrossRef

50.

Paukert AL, LeMaire A, Cully JA (2009) Predictors of depressive symptoms in older veterans with heart failure. Aging Ment Health 13(4):601–610PubMedCrossRef

51.

Devins GM, Bezjak A, Mah K et al (2006) Context moderates illness-induced lifestyle disruptions across life domains: a test of the illness intrusiveness theoretical framework in six common cancers. Psychooncology 15(3):221–233PubMedCrossRef

52.

Thakur ER, Sansgiry S, Petersen NJ et al (2017) Cognitive and perceptual factors, not disease severity, are linked with anxiety in COPD: results from a cross-sectional study. Int J Behav Med. doi:10.1007/s12529-017-9663-2 PubMed

53.

Gomberg-Maitland M, Thenappan T, Rizvi K et al (2008) United States validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR). J Heart Lung Transplant 27(1):124–130PubMedCrossRef

54.

Twiss J, McKenna S, Ganderton L et al (2013) Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension. BMC Pulm Med 13:45PubMedPubMedCentralCrossRef

55.

Hoeper MM, Pletz MW, Golpon H et al (2007) Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 29(5):944–950PubMedCrossRef

56.

Liu WH, Luo Q, Liu ZH et al (2014) Differences in exercise capacity in patients with chronic left heart failure and chronic right heart failure. Heart Lung Circ 23(11):1036–1040PubMedCrossRef

57.

Dumitrescu D, Oudiz RJ, Karpouzas G et al (2010) Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS ONE 5(12):e14293PubMedPubMedCentralCrossRef

58.

Held M, Grün M, Holl R et al (2014) Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration 87(5):379–387PubMedCrossRef

59.

Scheidl SJ, Englisch C, Kovacs G et al (2012) Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. Eur Respir J 39(1):119–124PubMedCrossRef

60.

Pepke-Zaba J, Delcroix M, Lang I et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124(18):1973–1981PubMedCrossRef

61.

Parshall MB, Schwartzstein RM, Adams L et al (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185(4):435–452PubMedPubMedCentralCrossRef

62.

Bass JJ (1990) Dyspnea. In: Walker HK, Hall WD, Hurst JW (eds) Clinical methods: the history, physical, and laboratory examinations. Butterworths, Boston

63.

Smoller JW, Pollack MH, Otto MW et al (1996) Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med 154(1):6–17PubMedCrossRef

64.

Lansing RW, Gracely RH, Banzett RB (2009) The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 167(1):53–60PubMedCrossRef

65.

Riera HS, Rubio TM, Ruiz FO et al (2001) Inspiratory muscle training in patients with COPD: effect on dyspnea, exercise performance, and quality of life. Chest 120(3):748–756CrossRef

66.

Smith EL, Hann DM, Ahles TA et al (2001) Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manag 21(4):323–329CrossRef

67.

de Voogd JN, Sanderman R, Postema K et al (2011) Relationship between anxiety and dyspnea on exertion in patients with chronic obstructive pulmonary disease. Anxiety Stress Coping 24(4):439–449PubMedCrossRef

Titel: Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH
verfasst von: Elena Pfeuffer
Holger Krannich
Michael Halank
Heinrike Wilkens
Philipp Kolb
Berthold Jany
Matthias Held
Publikationsdatum: 09.10.2017
Verlag: Springer US
Erschienen in: Lung / Ausgabe 6/2017
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-017-0052-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH

Abstract

Background

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Diet and Respiratory Health in Children from 11 Latin American Countries: Evidence from ISAAC Phase III

The Rare Complication and Diagnostic Challenges of Pulmonary Eosinophilia in Graft versus Host Disease Patients after Hematopoietic Stem Cell Transplantation

Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies

Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion

The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients

Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin